Novo Nordisk does not expect the Chinese patent for semaglutide to expire until 2027 - medwatch.com
Novo Nordisk does not expect the Chinese patent for semaglutide to expire until 2027 medwatch.com
Novo Nordisk does not expect the Chinese patent for semaglutide to expire until 2027 medwatch.com
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.